Mylène Vaillancourt
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 10%
- Cancer Research
- Surgery
- Co-authors
- Grégoire RuffenachSébastien BonnetJolyane MelocheSteeve ProvencherMansoureh EghbaliÈve TremblayFrançois PotusSandra Breuils‐Bonnet
- Topics
- Pulmonary Hypertension Research and Treatments (8 papers)Bacterial biofilms and quorum sensing (4 papers)Antibiotic Resistance in Bacteria (3 papers)
- Partner nations
- United StatesCanadaNorway
In The Last Decade
Mylène Vaillancourt
17 papers receiving 739 citations
Peers
Comparison fields: 5 of 81
- Pulmonary and Respiratory Medicine 495
- Molecular Biology 254
- Cardiology and Cardiovascular Medicine 230
- Cancer Research 126
- Surgery 87
Countries citing papers authored by Mylène Vaillancourt
This map shows the geographic impact of Mylène Vaillancourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mylène Vaillancourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mylène Vaillancourt more than expected).
Fields of papers citing papers by Mylène Vaillancourt
This network shows the impact of papers produced by Mylène Vaillancourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mylène Vaillancourt. The network helps show where Mylène Vaillancourt may publish in the future.
Co-authorship network of co-authors of Mylène Vaillancourt
This figure shows the co-authorship network connecting the top 25 collaborators of Mylène Vaillancourt. A scholar is included among the top collaborators of Mylène Vaillancourt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mylène Vaillancourt. Mylène Vaillancourt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 20 | |
| 4 | 9 | |
| 5 | 1 | |
| 6 | 21 | |
| 7 | 56 | |
| 8 | 14 | |
| 9 | 9 | |
| 10 | 18 | |
| 11 | 15 | |
| 12 | 97 | |
| 13 | 133 | |
| 14 | 86 | |
| 15 | 23 | |
| 16 | 198 | |
| 17 | 24 | |
| 18 | 24 |
About Mylène Vaillancourt
Mylène Vaillancourt is a scholar working on Molecular Medicine, Endocrinology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 749 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (8 papers), Bacterial biofilms and quorum sensing (4 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (495 citations), Cardiology and Cardiovascular Medicine (230 citations) and Cancer Research (126 citations). Mylène Vaillancourt has collaborated with scholars based in United States, Canada and Norway. Frequent co-authors include Grégoire Ruffenach, Sébastien Bonnet, Jolyane Meloche, Steeve Provencher, Mansoureh Eghbali, Ève Tremblay, François Potus, Sandra Breuils‐Bonnet, Colin Graydon and Aude Pflieger. Their work appears in journals such as Circulation, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.